Assunta Sgambato
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 25
- Oncology 23
- Lung Cancer Research Studies 14
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 3
- Co-authors
- Cesare Gridelli (30 shared papers)Francesca Casaluce (31 shared papers)Paolo Maione (25 shared papers)Fortunato Ciardiello (12 shared papers)Antônio Rossi (20 shared papers)Paola Claudia Sacco (14 shared papers)Giovanni Palazzolo (13 shared papers)Solange Peters (1 shared paper)
- Journals
- Current Pharmaceutical Design (4 papers)Expert Opinion on Pharmacotherapy (3 papers)Reviews on Recent Clinical Trials (2 papers)Expert Review of Anticancer Therapy (2 papers)Expert Opinion on Biological Therapy (2 papers)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Assunta Sgambato
31 papers receiving 729 citations
Peers
Comparison fields: 5 of 68
- Oncology 441
- Pulmonary and Respiratory Medicine 416
- Cancer Research 125
- Molecular Biology 293
- Immunology 66
Countries citing papers authored by Assunta Sgambato
This map shows the geographic impact of Assunta Sgambato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assunta Sgambato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assunta Sgambato more than expected).
Fields of papers citing papers by Assunta Sgambato
This network shows the impact of papers produced by Assunta Sgambato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assunta Sgambato. The network helps show where Assunta Sgambato may publish in the future.
Co-authors
The 25 scholars most cited alongside Assunta Sgambato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 142 | |
| 2 | 2017 | 65 | |
| 3 | 2015 | 63 | |
| 4 | 2013 | 62 | |
| 5 | 2015 | 52 | |
| 6 | 2017 | 27 | |
| 7 | 2016 | 26 | |
| 8 | 2014 | 26 | |
| 9 | 2013 | 24 | |
| 10 | 2015 | 23 | |
| 11 | 2017 | 23 | |
| 12 | 2018 | 22 | |
| 13 | 2013 | 20 | |
| 14 | 2016 | 14 | |
| 15 | 2012 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2014 | 13 | |
| 18 | 2016 | 12 | |
| 19 | 2016 | 12 | |
| 20 | 2013 | 12 |
About Assunta Sgambato
Assunta Sgambato is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Epidemiology, having authored 31 papers that have together received 742 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (14 papers), Cancer therapeutics and mechanisms (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Mechanisms and Therapy (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (441 citations), Pulmonary and Respiratory Medicine (416 citations), Cancer Research (125 citations), Molecular Biology (293 citations) and Immunology (66 citations). Assunta Sgambato has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Cesare Gridelli, Francesca Casaluce, Paolo Maione, Fortunato Ciardiello, Antônio Rossi, Paola Claudia Sacco, Giovanni Palazzolo, Solange Peters, Alex A. Adjei and Giuseppe Santabarbara. Their work appears in journals such as Current Pharmaceutical Design, Expert Opinion on Pharmacotherapy, Reviews on Recent Clinical Trials, Expert Review of Anticancer Therapy and Expert Opinion on Biological Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.